Nascent Biotech Appoints Chief Medical Consultant in Charge of COVID-19 Research

SAN DIEGO, June 24, 2020 (GLOBE NEWSWIRE) — Nascent Biotech, Inc. (OTC: NBIO) announced today that it has appointed Dr. Navpaul Singh MD as Chief Medical Consultant in charge of research into Pritumumab’s use with viral infections, including COVID-19.